Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma

Abstract Background Ovarian clear cell carcinoma (OCCC) is the second most common ovarian cancer after serous carcinoma in Japan. OCCC has a more unfavorable clinical outcome due to a poor response to platinum-based chemotherapy, compared with serous carcinoma. Hypoxia inducible factor-1α (HIF-1α) i...

Full description

Bibliographic Details
Main Authors: Hiroyuki Suzuki, Mitsutake Yano, Mariko Miyazawa, Masaki Miyazawa, Naoki Ogane, Kosei Hasegawa, Hitoshi Tsuda, Masayuki Yoshida, Ryugo Okagaki, Osamu Ishihara, Masanori Yasuda
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Journal of Ovarian Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13048-019-0481-9
id doaj-f258d5e0d7ec4a1791d8e6ee7fcb4b5e
record_format Article
spelling doaj-f258d5e0d7ec4a1791d8e6ee7fcb4b5e2020-11-25T01:15:44ZengBMCJournal of Ovarian Research1757-22152019-01-011211710.1186/s13048-019-0481-9Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinomaHiroyuki Suzuki0Mitsutake Yano1Mariko Miyazawa2Masaki Miyazawa3Naoki Ogane4Kosei Hasegawa5Hitoshi Tsuda6Masayuki Yoshida7Ryugo Okagaki8Osamu Ishihara9Masanori Yasuda10Department of Pathology, Saitama Medical University International Medical CenterDepartment of Pathology, Saitama Medical University International Medical CenterDepartment of Obstetrics and Gynecology, Tokai University School of MedicineDepartment of Obstetrics and Gynecology, Tokai University School of MedicineDivision of Pathology, Ashigarakami HospitalDepartment of Gynecologic Oncology, Saitama Medical University International Medical CenterDepartment of Basic Pathology, National Defense Medical CollegeDepartment of Pathology and Clinical Laboratories, National Cancer Center HospitalDepartment of Obstetrics and Gynecology, Saitama Medical University HospitalDepartment of Obstetrics and Gynecology, Saitama Medical University HospitalDepartment of Pathology, Saitama Medical University International Medical CenterAbstract Background Ovarian clear cell carcinoma (OCCC) is the second most common ovarian cancer after serous carcinoma in Japan. OCCC has a more unfavorable clinical outcome due to a poor response to platinum-based chemotherapy, compared with serous carcinoma. Hypoxia inducible factor-1α (HIF-1α) is a key regulator of cellular response to hypoxia and plays an important role in tumor growth, and HIF-1α gene single-nucleotide polymorphisms (SNPs) adversely affect the outcome in some cancers. Herein, we investigated the association of the HIF-1α gene SPNs with clinical outcome in OCCCs. Eighty-nine patients with OCCC were recruited in whom pathological diagnosis was confirmed with surgically resected specimen. Results The SNPs of C1772T and G1790A in the HIF-1α gene occurred in 23.6 and 3.3% of the patients, respectively. In the univariate analysis, overall survival was associated with stage and surgical residual tumor but not with the SNPs C1772T, G1790A, C1772T and/or G1790A. In the multivariate survival analysis, a significant association was observed between outcome and FIGO stage and/or surgical residual tumor; however, no association was obtained between HIF-1α gene SNPs and these factors. Conclusion In conclusion, unlike the other cancers in which HIF-1α gene SNPs were demonstrated to be associated with the outcome, OCCC prognosis may not be affected by HIF-1α gene SNPs. Further studies need to be performed to clarify the association of HIF-1α expression with the unfavorable prognosis in OCCCs, in terms of transcriptional/translational activity, nuclear translocation of the protein, and protein degradation.http://link.springer.com/article/10.1186/s13048-019-0481-9Ovarian clear cell carcinomaSingle-nucleotide polymorphisms (SNPs)Hypoxia-inducible factor-1α (HIF-1α)Prognosis
collection DOAJ
language English
format Article
sources DOAJ
author Hiroyuki Suzuki
Mitsutake Yano
Mariko Miyazawa
Masaki Miyazawa
Naoki Ogane
Kosei Hasegawa
Hitoshi Tsuda
Masayuki Yoshida
Ryugo Okagaki
Osamu Ishihara
Masanori Yasuda
spellingShingle Hiroyuki Suzuki
Mitsutake Yano
Mariko Miyazawa
Masaki Miyazawa
Naoki Ogane
Kosei Hasegawa
Hitoshi Tsuda
Masayuki Yoshida
Ryugo Okagaki
Osamu Ishihara
Masanori Yasuda
Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma
Journal of Ovarian Research
Ovarian clear cell carcinoma
Single-nucleotide polymorphisms (SNPs)
Hypoxia-inducible factor-1α (HIF-1α)
Prognosis
author_facet Hiroyuki Suzuki
Mitsutake Yano
Mariko Miyazawa
Masaki Miyazawa
Naoki Ogane
Kosei Hasegawa
Hitoshi Tsuda
Masayuki Yoshida
Ryugo Okagaki
Osamu Ishihara
Masanori Yasuda
author_sort Hiroyuki Suzuki
title Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma
title_short Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma
title_full Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma
title_fullStr Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma
title_full_unstemmed Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma
title_sort association of the hypoxia-inducible factor-1α (hif-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma
publisher BMC
series Journal of Ovarian Research
issn 1757-2215
publishDate 2019-01-01
description Abstract Background Ovarian clear cell carcinoma (OCCC) is the second most common ovarian cancer after serous carcinoma in Japan. OCCC has a more unfavorable clinical outcome due to a poor response to platinum-based chemotherapy, compared with serous carcinoma. Hypoxia inducible factor-1α (HIF-1α) is a key regulator of cellular response to hypoxia and plays an important role in tumor growth, and HIF-1α gene single-nucleotide polymorphisms (SNPs) adversely affect the outcome in some cancers. Herein, we investigated the association of the HIF-1α gene SPNs with clinical outcome in OCCCs. Eighty-nine patients with OCCC were recruited in whom pathological diagnosis was confirmed with surgically resected specimen. Results The SNPs of C1772T and G1790A in the HIF-1α gene occurred in 23.6 and 3.3% of the patients, respectively. In the univariate analysis, overall survival was associated with stage and surgical residual tumor but not with the SNPs C1772T, G1790A, C1772T and/or G1790A. In the multivariate survival analysis, a significant association was observed between outcome and FIGO stage and/or surgical residual tumor; however, no association was obtained between HIF-1α gene SNPs and these factors. Conclusion In conclusion, unlike the other cancers in which HIF-1α gene SNPs were demonstrated to be associated with the outcome, OCCC prognosis may not be affected by HIF-1α gene SNPs. Further studies need to be performed to clarify the association of HIF-1α expression with the unfavorable prognosis in OCCCs, in terms of transcriptional/translational activity, nuclear translocation of the protein, and protein degradation.
topic Ovarian clear cell carcinoma
Single-nucleotide polymorphisms (SNPs)
Hypoxia-inducible factor-1α (HIF-1α)
Prognosis
url http://link.springer.com/article/10.1186/s13048-019-0481-9
work_keys_str_mv AT hiroyukisuzuki associationofthehypoxiainduciblefactor1ahif1agenepolymorphismswithprognosisinovarianclearcellcarcinoma
AT mitsutakeyano associationofthehypoxiainduciblefactor1ahif1agenepolymorphismswithprognosisinovarianclearcellcarcinoma
AT marikomiyazawa associationofthehypoxiainduciblefactor1ahif1agenepolymorphismswithprognosisinovarianclearcellcarcinoma
AT masakimiyazawa associationofthehypoxiainduciblefactor1ahif1agenepolymorphismswithprognosisinovarianclearcellcarcinoma
AT naokiogane associationofthehypoxiainduciblefactor1ahif1agenepolymorphismswithprognosisinovarianclearcellcarcinoma
AT koseihasegawa associationofthehypoxiainduciblefactor1ahif1agenepolymorphismswithprognosisinovarianclearcellcarcinoma
AT hitoshitsuda associationofthehypoxiainduciblefactor1ahif1agenepolymorphismswithprognosisinovarianclearcellcarcinoma
AT masayukiyoshida associationofthehypoxiainduciblefactor1ahif1agenepolymorphismswithprognosisinovarianclearcellcarcinoma
AT ryugookagaki associationofthehypoxiainduciblefactor1ahif1agenepolymorphismswithprognosisinovarianclearcellcarcinoma
AT osamuishihara associationofthehypoxiainduciblefactor1ahif1agenepolymorphismswithprognosisinovarianclearcellcarcinoma
AT masanoriyasuda associationofthehypoxiainduciblefactor1ahif1agenepolymorphismswithprognosisinovarianclearcellcarcinoma
_version_ 1725151542401564672